Overcoming radioresistance in WiDr cells with heavy ion irradiation and radiosensitization by 2-deoxyglucose with photon irradiation

Clinical and Translational Radiation Oncology - Tập 19 - Trang 52-58 - 2019
Felix Christian Hasse1, Stefan Alexander Koerber1, Elena Sophie Prigge2, Jakob Liermann1, Magnus von Knebel Doeberitz2, Juergen Debus1, Florian Sterzing1
1Department of Radiation Oncology, University Hospital Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany
2Department of Applied Tumor Biology, Institute of Pathology, University Hospital Heidelberg, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany

Tài liệu tham khảo

Torre, 2015, Global cancer statistics, 2012, CA Cancer J Clin, 65, 87, 10.3322/caac.21262 Siegel, 2016, Cancer statistics, 2016, CA Cancer J Clin, 66, 7, 10.3322/caac.21332 Fuccio, 2012, Management of intestinal complications in patients with pelvic radiation disease, Clin Gastro-enterol Hepatol, 10, 1326, 10.1016/j.cgh.2012.07.017 Sterzing, 2015, Clinical results and toxicity for short-course preoperative radiotherapy and total mesorectal excision in rectal cancer patients, J Radiat Res, 56, 169, 10.1093/jrr/rru089 Kirchheiner, 2016, Health-related quality of life in locally advanced cervical cancer patients after definitive chemoradiation therapy including image guided adaptive brachytherapy: an analysis from the EMBRACE study, Int J Radiat Oncol Biol Phys, 94, 1088, 10.1016/j.ijrobp.2015.12.363 Jensen, 2015, Pelvic radiotherapy and sexual function in women, Transl Androl Urol, 4, 186 Jiang, 2012, Particle therapy for cancers: a new weapon in radiation therapy, Front Med, 6, 165, 10.1007/s11684-012-0196-4 Aoki-Nakano, 2013, Misrepair of DNA double-strand breaks after exposure to heavy-ion beams causes a peak in the LET–RBE relationship with respect to cell killing in DT40 cells, J Radiat Res, 54, 1029, 10.1093/jrr/rrt064 Durante, 2014, New challenges in high-energy particle radiobiology, Br J Radiol, 87, 20130626, 10.1259/bjr.20130626 Takuro, 2015, Treatment outcomes of patients with FIGO Stage I/II uterine cervical cancer treated with definitive radiotherapy: a multi-institutional retrospective research study, J Radiat Res, 56, 841, 10.1093/jrr/rrv036 Noura, 2014, Irradiation with carbon ions for locally recurrent rectal cancer, Gan To Kagaku Ryoho, 41, 1713 Okada, 2014, Rectal cancer with local re-recurrence successfully treated by carbon ion radiotherapy, Gan To Kagaku Ryoho, 41, 1710 Wakatsuki, 2015, Clinical trial of prophylactic extended-field carbon-ion radiotherapy for locally advanced uterine cervical cancer (Protocol 0508), PLoS ONE, 10, 10.1371/journal.pone.0127587 Bandugula, 2013, 2-Deoxy-D-glucose and ferulic acid modulates radiation response signaling in non-small cell lung cancer cells, Tumour Biol, 34, 251, 10.1007/s13277-012-0545-6 Lin, 2003, 2-Deoxy-D-glucose-induced cytotoxicity and radiosensitization in tumor cells is mediated via disruptions in thiol metabolism, Cancer Res, 63, 3413 Mohanti, 1996, Improving cancer radiotherapy with 2-deoxy-D-glucose: phase I/II clinical trials on human cerebral gliomas, Int J Radiat Oncol Biol Phys, 35, 103, 10.1016/S0360-3016(96)85017-6 Vander Heiden, 2011, Targeting cancer metabolism: a therapeutic window opens, Nat Rev Drug Discov, 10, 671, 10.1038/nrd3504 Kern, 1987, Inhibition of established rat fibrosarcoma growth by the glucose antagonist 2-deoxy-D-glucose, Surgery, 102, 380 Shinjo, 2013, Comparative analysis of the expression patterns of UPR-target genes caused by UPR-inducing compounds, Biosci Biotechnol Biochem, 77, 729, 10.1271/bbb.120812 Matsumura, 2014, Inhibition of cancer cell growth by GRP78 siRNA lipoplex via activation of unfolded protein response, Biol Pharm Bull, 37, 648, 10.1248/bpb.b13-00930 Blackburn, 1999, Metabolic oxidative stress activates signal transduction and gene expression during glucose deprivation in human tumor cells, Free Radic. Biol. Med, 26, 419, 10.1016/S0891-5849(98)00217-2 Spitz, 2000, Glucose deprivation-induced oxidative stress in human tumor cells: a fundamental defect in metabolism?, Ann NY Acad Sci, 899, 349, 10.1111/j.1749-6632.2000.tb06199.x Lee, 1998, Glucose deprivation-induced cytotoxicity and alterations in mitogen-activated protein kinase activation are mediated by oxidative stress in multidrug-resistant human breast carcinoma cells, J Biol Chem, 273, 5294, 10.1074/jbc.273.9.5294 Kawata, 2017, Additive effect of radiosensitization by 2-deoxy-D-glucose delays DNA repair kinetics and suppresses cell proliferation in oral squamous cell carcinoma, J Oral Pathol Med, 46, 979 Jha, 1992, Effect of 2-deoxy-D-glucose on DNA double strand break re-pair, cell survival and energy metabolism in euoxic Ehrlich ascites tumour cells, Int J Radiat Biol, 62, 409, 10.1080/09553009214552291 Mühlenberg, 2015, Inhibition of KIT-glycosylation by 2-deoxyglucose abrogates KIT-signaling and combination with ABT-263 synergistically induces apoptosis in gastrointestinal stromal tumor, PLoS One, 10, 10.1371/journal.pone.0120531 Sun, 2017, Dual inhibition of glycolysis and glutaminolysis as a therapeutic strategy in the treatment of ovarian cancer, Oncotarget, 8, 63551, 10.18632/oncotarget.18854 Chatterjee, 2015, Combined 2-deoxy glucose and metformin improves therapeutic efficacy of sodium-iodide symporter-mediated targeted radioiodine therapy in breast cancer cells, Breast Cancer (Dove Med Press), 7, 251 Steel, 1979, Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity, Int J Radiat Oncol Biol Phys, 5, 85, 10.1016/0360-3016(79)90044-0 Paganetti, 2018, Proton relative biological effectiveness – uncertainties and opportunities, Int J Particle Ther, 5, 2, 10.14338/IJPT-18-00011.1 Datta, 2005, Variations in clinical estimates of tumor volume regression parameters and time factor during external radiotherapy in cancer cervix: does it mimic the linear-quadratic model of cell survival?, Indian J Cancer, 42, 70, 10.4103/0019-509X.16695 Suwinski, 2007, Moderately low alpha/beta ratio for rectal cancer may best explain the outcome of three fractionation schedules of preoperative radiotherapy, Int J Radiat Oncol Biol Phys, 69, 793, 10.1016/j.ijrobp.2007.03.046 Schlaich, 2013, Comparison of the effects of photon versus carbon ion irradiation when combined with chemotherapy in vitro, Radiat Oncol, 8, 260, 10.1186/1748-717X-8-260 Habermehl, 2014, The relative biological effectiveness for carbon and oxygen ion beams using the raster-scanning technique in hepatocellular carcinoma cell lines, PLoS ONE, 9, 10.1371/journal.pone.0113591 van Leeuwen, 2018, The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies, Radiat Oncol, 13, 96, 10.1186/s13014-018-1040-z Fan, 2013, Berberine combined with 2-deoxy-d-glucose synergistically enhances cancer cell proliferation inhibition via energy depletion and unfolded protein response disruption, Biochim Biophys Acta, 1830, 5175, 10.1016/j.bbagen.2013.07.010 Kalia, 2009, Modulation of cellular radiation responses by 2-deoxy-D-glucose and other glycolytic inhibitors: implications for cancer therapy, J Cancer Res Ther, 5, 57, 10.4103/0973-1482.55145 Perumal, 2009, Modification of 2-deoxy-D-glucose on radiation-and chemo-therapeutic drug-induced chromosomal aberrations, J Cancer Res Ther, 5, 48, 10.4103/0973-1482.55142 Sharma, 2012, 2-Deoxy-D-glucose and 6-aminonicotinamide-mediated Nrf2 down regulation leads to radiosensitization of malignant cells via abrogation of GSH-mediated defense, Free Radic Res, 46, 1446, 10.3109/10715762.2012.724771 Dwarakanath, 1999, Optimization of tumour radiotherapy: Part V-radiosensitization by 2-deoxy-D-glucose and DNA ligand Hoechst-33342 in a murine tumour, Indian J Exp Biol, 37, 865 Dwarkanath, 2001, Heterogeneity in 2-deoxy-D-glucose-induced modifications in energetics and radiation responses of human tumor cell lines, Int J Radiat Oncol Biol Phys, 50, 1051, 10.1016/S0360-3016(01)01534-6 Rashmi, 2018, Radioresistant cervical cancers are sensitive to inhibition of glycolysis and redox metabolism, Cancer Res, 78, 1392, 10.1158/0008-5472.CAN-17-2367 Harrabi, 2013, Temozolomide in combination with carbon ion or photon irradiation in glioblastoma multiforme cell lines – does scheduling matter?, Int J Radiat Biol, 89, 692, 10.3109/09553002.2013.791406 El Shafie, 2013, In vitro evaluation of photon and raster-scanned carbon ion radiotherapy in combination with gemcitabine in pancreatic cancer cell lines, J Radiat Res, 54, i113, 10.1093/jrr/rrt052 Combs, 2012, In vitro evaluation of photon and carbon ion radiotherapy in combination with chemotherapy in glioblastoma cells, Radiat Oncol, 7, 9, 10.1186/1748-717X-7-9 Ma, 2015, Combining carbon ion irradiation and non-homologous end-joining repair inhibitor NU7026 efficiently kills cancer cells, Radiat Oncol, 10, 225, 10.1186/s13014-015-0536-z Kubo, 2015, Radiosensitizing effect of carboplatin and paclitaxel to carbon-ion beam irradiation in the non-small-cell lung cancer cell line H460, J Radiat Res, 56, 229, 10.1093/jrr/rru085 Fujisawa, 2015, VE-821, an ATR inhibitor, causes radiosensitization in human tumor cells irradiated with high LET radiation, Radiat Oncol, 10, 175, 10.1186/s13014-015-0464-y Sage, 2017, Radiation-induced clustered DNA lesions: Repair and mutagenesis, Free Radic Biol Med, 107, 125, 10.1016/j.freeradbiomed.2016.12.008 Khanna, 2001, DNA double-strand breaks: signaling, repair and the cancer connection, Nat Genet, 27, 247, 10.1038/85798 Ceccaldi, 2016, Repair pathway choices and consequences at the double-strand break, Trends Cell Biol, 26, 52, 10.1016/j.tcb.2015.07.009 Zhao, 2015, A generalized target theory and its applications, Sci Rep, 28, 14568, 10.1038/srep14568 Combs, 2011, Carbon ion radiotherapy performed as re-irradiation using active beam delivery in patients with tumors of the brain, skull base and sacral region, Radiother Oncol, 98, 63, 10.1016/j.radonc.2010.10.010 Jensen, 2016, High-LET radiotherapy for adenoid cystic carcinoma of the head and neck: 15 years' experience with raster-scanned carbon ion therapy, Radiother Oncol, 118, 272, 10.1016/j.radonc.2015.05.010 Raez, 2007, Responses to the combination of the glycolytic inhibitor 2-deoxy-glucose (2DG) and docetaxel (DC) in patients with lung and head and neck (H/N) carcinomas, J Clin Oncol, 25, 14025, 10.1200/jco.2007.25.18_suppl.14025 Stein, 2010, Targeting tumor metabolism with 2-deoxyglucose in patients with castrate-resistant prostate cancer and advanced malignancies, Prostate, 70, 1388, 10.1002/pros.21172